학술논문
High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan
Document Type
Article
Author
Nieto, Yago; Valdez, Benigno C; Pingali, Sai R; Bassett, Roland; Delgado, Ruby; Nguyen, John; Shah, Nina; Popat, Uday; Jones, Roy B; Andersson, Borje S; Gulbis, Alison; Ahmed, Sairah; Bashir, Qaiser; Parmar, Simrit; Patel, Krina; Myers, Alan; Rondon, Gabriela; Orlowski, Robert Z; Champlin, Richard; Qazilbash, Muzaffar
Source
In The Lancet Haematology June 2017 4(6):e283-e292
Subject
Language
ISSN
2352-3026